Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Isotoxic High Dose (iHD) Fractionated Stereotactic Radiation Therapy (fSRT) for Intact Brain Metastases : a Feasibility Study

NCT06231186 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT06231186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06231186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Isotoxic High Dose (iHD) Fractionated Stereotactic Radiation Therapy (fSRT) for Intact Brain Metastases : a Feasibility Study
Lead sponsor
Ruijin Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 15, 2024
Completion date
December 31, 2026
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, adult, stereotactic radiotherapy